Subsite specificity of memapsin 2 (beta-secretase): implications for inhibitor design

R T Turner1, G Koelsch, L Hong

  • 1Protein Studies Program, Oklahoma Medical Research Foundation, and Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA.

Biochemistry
|August 22, 2001
PubMed

Insights

Memapsin 2, or beta-secretase, is crucial for Alzheimer's disease pathogenesis. Researchers mapped its residue preferences to design potent inhibitors, leading to the discovery of OM00-3, the most effective inhibitor to date.

Area of Science:

  • Biochemistry
  • Enzymology
  • Neuroscience

Background:

  • Memapsin 2 (beta-secretase) cleaves beta-amyloid precursor protein, producing beta-amyloid peptides.
  • Beta-amyloid accumulation is a key factor in Alzheimer's disease pathogenesis.
  • Memapsin 2 is a significant therapeutic target for Alzheimer's disease drug design.

Purpose of the Study:

  • To determine the residue preferences for the subsites of memapsin 2.
  • To identify optimal residues for designing potent memapsin 2 inhibitors.
  • To characterize the binding interactions of novel inhibitors with memapsin 2.

Main Methods:

  • Relative k(cat)/K(M) values determined using substrate mixtures and MALDI-TOF mass spectrometry.
  • Analysis of binding affinities of memapsin 2 to a combinatorial inhibitor library.
  • Molecular modeling of inhibitor-enzyme interactions.

Main Results:

  • Each memapsin 2 subsite accommodates multiple residues, with S(1) being the most stringent.
  • A peptide with the eight most favored residues showed the highest k(cat)/K(M) value.
  • The inhibitor OM00-3, designed from consensus residues, exhibited a K(i) of 3.1 x 10(-10) M, the most potent reported.

Conclusions:

  • Detailed residue preferences for memapsin 2 subsites were elucidated.
  • These findings facilitate the rational design of highly potent memapsin 2 inhibitors.
  • OM00-3 represents a significant advancement in developing therapeutic agents for Alzheimer's disease.

Related Concept Videos

Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Enzymes02:34

Enzymes

Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...